Biogen has agreed to buy UK-based gene therapy ... is caused by loss of function in the CHM which encodes the Rab escort protein -1 (REP-1), which plays a role in intracellular protein trafficking.

We are encouraged by the FDA’s Fast Track designation for BIIB080, which highlights the urgent need for innovative treatments targeting tau pathology in Alzheimer’s disease,” said Priya Singhal, M.D., ...

Biogen has revealed encouraging phase 2 results ... is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. It is thought that CD38-expressing ...

Leucine-rich repeat and immunoglobulin-like domain-containing protein 1 (LINGO-1), which was discovered by Biogen, 16 suppresses oligodendrocyte differentiation, axonal regeneration, and neuronal ...